Protein lactylation in atherosclerosis – Mechanisms and therapeutic potential: A narrative review
Open Access
- 22 October 2026
- journal article
- review article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
Abstract
Protein lactylation, which links cellular metabolism to gene regulation and protein function, may influence atherosclerosis. This narrative review explores its cellular mechanisms and therapeutic potential. We searched PubMed from inception to September 30, 2026, for English-language studies and reviews. The synthesis differentiated lactylation from lactate signaling and distinguished direct evidence in atherosclerosis from findings in other disease models. Predominantly preclinical evidence suggests that both histone and non-histone lactylation are involved in endothelial inflammation, endothelial-to-mesenchymal transition, macrophage polarization and ferroptosis, and vascular smooth muscle cell senescence, phenotypic remodeling, and calcification. Depending on the cellular context, modification site, and downstream targets, lactylation can either promote vascular injury or support anti-inflammatory responses and plaque stabilization. Candidate interventions target lactate production, transport, and lactylation-related enzymes, but their effects often lack specificity for lactylation. Much of the therapeutic evidence originates from non-atherosclerotic models, and clinical validation is currently absent. Therefore, therapeutic development should consider cell type, disease stage, and modification site, with validation of causal mechanisms, selectivity, and safety in atherosclerosis models prior to clinical translation.Keywords
This publication has 104 references indexed in Scilit:
- Narciclasine Alleviates Endothelial Inflammation and Atherosclerosis Initiation by Inhibiting Histone Lactylation-Mediated NF-κB ActivationInflammation, 2026
- The Emerging Role of Lactate and Lactylation Modifications in the Pathophysiology of Atherosclerotic Cardiovascular DiseasesCardiovascular Drugs and Therapy, 2025
- Lactate‐Activated GPR132‐Src Signal Induces Macrophage Senescence and Aggravates Atherosclerosis Under DiabetesAdvanced Science, 2025
- Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentialsClinical and Translational Medicine, 2024
- Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem CellsAdvanced Science, 2024
- ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMTActa Pharmaceutica Sinica B, 2024
- Advances in Glycolysis Metabolism of AtherosclerosisJournal of Cardiovascular Translational Research, 2022
- Chronic Kidney Disease: Mitochondrial Damage‐Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease‐Associated Plaque Vulnerability (Adv. Sci. 5/2021)Advanced Science, 2021
- Activation of GPR81 by lactate inhibits oscillatory shear stress‐induced endothelial inflammation by activating the expression of KLF2IUBMB Life, 2019
- Monocyte and macrophage immunometabolism in atherosclerosisSeminars in Immunopathology, 2017